News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Ichor Medical Systems, Inc. and Profectus BioSciences, Inc. Enter into an Agreement for Use of TriGrid(TM) Electroporation Device to Develop Multiple DNA Vaccines


3/2/2010 10:28:38 AM

SAN DIEGO & BALTIMORE--(BUSINESS WIRE)--Ichor Medical Systems (Ichor) and Profectus Biosciences (Profectus) announced today that they have entered into a long-term development, license, and supply Agreement providing Profectus with commercial access to Ichor’s TriGrid™ Delivery System (TriGrid™) for the clinical development of its DNA vaccine programs, with an option for Ichor to co-develop.

Read at BioSpace.com

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES